Table 2.
Demographics and HbA1c of All Age Patients and >19 y of Age With Extreme Insulin Resistance at the Time of Thyroid Imaging
Parameter/Disease | All Patients |
Patients <19 y of Age |
||||
---|---|---|---|---|---|---|
INSR Mutation (n = 11) | Lipodystrophy (n = 81) | P Value | INSR Mutation (n = 7) | Lipodystrophy (n = 23) | P Value | |
Age, ya | 18.1 ± 10.6 (7–47) | 30.9 ± 18 (1–79) | 0.01 | 13.1 ± 3.9 (7–18) | 13.2 ± 4.6 (2–18) | 0.81 |
% Male | 45 | 16 | 0.036 | 43 | 22 | 0.34 |
BSA, m2 | 1.34 ± 0.36 | 1.67 ± 0.3 | 0.006 | 1.28 ± 0.34 | 1.42 ± 0.4 | 0.33 |
BMI | 21.2 ± 4.4 | 23.3 ± 5 | 0.2 | 19.3 ± 3.2 | 19.6 ± 4.7 | 0.8 |
% on Metreleptin | 36 | 67 | 0.048 | 29 | 70 | 0.08 |
HbA1c, % (range) | 8.5 ± 3.1 (4.8–13.3); | 7.1 ± 2.1 (4.3–13.2); | 0.2 | 8.2 ± 2 (5.3–10.8): | 6.42 ± 2 (4.3–11); | 0.04 |
n = 11 | n = 76 | n = 7 | n = 22 |
Boldface indicates statistically significant P value (P < 0.05).
Age is given as mean ± SD (range).